Figure 4From: Telomerase immunity from bench to bedside: round oneThe cytotoxic activity of CD8 T cells expanded in vitro (R4) from lymphocytes of subject #112 of cohort 4a who received two injections of freshly prepared transgenic lymphocytes at the dose of 0.5 × 105 each one month apart. Upper panel: lysis of T2 cells with (close symbols) or without (open symbols) p540. Lower panel: lyses of MCF-7 (open symbols) or PC3 (close symbols) tumor cells. Data in both panels refer to a single experiment where the values of triplicate wells were within 5% variation.Back to article page